Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.

医学 肌肉痉挛 可视模拟标度 替扎尼定 麻醉 腰痛 肌肉痉挛 止痛药 肌肉张力 人口 物理疗法 物理医学与康复 痉挛 环境卫生 病理 替代医学
作者
Darius F. Soonawalla,Niteen Joshi
出处
期刊:PubMed 卷期号:106 (5): 331-5 被引量:11
链接
标识
摘要

Low back pain (LBP), a high prevalent condition among middle aged population, is usually associated with 'muscle spasm' that is responsible for giving rise to pain as well as its persistence. Muscle spasm is an involuntary, painful contraction of muscles that interferes with the function and cause of muscular disorder. Therefore centrally acting skeletal muscle relaxants, also called lissive drugs, are commonly used for its treatment. Sometimes these are combined with NSAIDs. The use of centrally acting skeletal muscle relaxants, though efficacious, is associated with frequent development of dose-related adverse drug reactions like sedation, impairment of voluntary motor functions and ataxia. So there is an urgent need for newer better drugs for treatment of conditions associated with muscle spasm. The objective of this study was to assess the efficacy and safety of oral thiocolchicoside (TC), a natural glycoside as compared to an adrenergic alpha 2 agonist tizanidine (TZ) in the Indian patients with LBP accompanied by muscle spasm. In this randomised, non-cross over clinical study, 60 adult Indians aged between 18 and 65 years with clinical diagnosis of muscle spasm associated with low back pain were enrolled. Patients satisfying the inclusion and exclusion criteria were either treated with TC and TZ for one week duration. Visual analogue scale (VAS) for pain at rest and VAS for tiredness, drowsiness, dizziness and alertness was used as the self-rated primary efficacy and safety variable. Pain was also assessed by mobility assessment; muscle spasm assessment and analgesic consumption. Data obtained from 58 patients (those who completed the study) indicated that in this one week study both TC and TZ provided sustained symptoms relief compared with the baseline. There was statistically significant reduction in severity of symptoms from day 0 to day 7 in both the groups. Patients were followed up on 3rd and 7th day and severity score of various parameters was recorded. There was significant difference among the treatment groups in favour of TC than TZ in efficacy parameters thus showing TC is at slightly better effective than TZ and in case of safety, TC scores significantly better over TZ in the patients with accompanying muscle spasm. These findings confirm that TC is a preferred option for the LBP with muscle spasms.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白桃发布了新的文献求助10
1秒前
酷波er应助山月为衾采纳,获得10
2秒前
木木发布了新的文献求助10
3秒前
linyalala完成签到,获得积分20
5秒前
dyj发布了新的文献求助10
5秒前
6秒前
凌云完成签到,获得积分10
6秒前
冰可乐完成签到 ,获得积分10
7秒前
Andy完成签到,获得积分10
7秒前
领导范儿应助枝江泥头车采纳,获得10
7秒前
乐于曰发布了新的文献求助10
9秒前
9秒前
brightjoe完成签到 ,获得积分0
10秒前
10秒前
小钱发布了新的文献求助20
13秒前
li完成签到,获得积分10
13秒前
Setsail24k完成签到,获得积分10
13秒前
13秒前
Singularity应助Alvin采纳,获得10
14秒前
木子Q发布了新的文献求助10
14秒前
难过初柔发布了新的文献求助10
14秒前
15秒前
mengloo完成签到,获得积分10
15秒前
枝江泥头车完成签到,获得积分10
17秒前
echoMe完成签到 ,获得积分10
19秒前
千祜完成签到,获得积分20
19秒前
19秒前
柯忻完成签到,获得积分10
22秒前
CodeCraft应助孙英苹采纳,获得100
22秒前
Lett发布了新的文献求助100
22秒前
22秒前
聪明邪欢完成签到,获得积分10
23秒前
23秒前
小怪发布了新的文献求助10
23秒前
24秒前
Mona完成签到,获得积分10
25秒前
个性的紫菜应助鲤鱼谷波采纳,获得20
26秒前
山月为衾发布了新的文献求助10
29秒前
可爱迪应助朱问安采纳,获得10
30秒前
31秒前
高分求助中
请在求助之前详细阅读求助说明 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 500
Revolutions 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2461009
求助须知:如何正确求助?哪些是违规求助? 2130705
关于积分的说明 5428758
捐赠科研通 1857832
什么是DOI,文献DOI怎么找? 923952
版权声明 562463
科研通“疑难数据库(出版商)”最低求助积分说明 494280